Rapamycin has been trending on social media, where biohackers such as Dr. Peter Attia and Bryan Johnson tout it as the “gold standard” for people seeking to live a longer, healthier life. Rapamycin is ...
Rapamycin is a drug used to suppress the immune system in transplant patients, but scientists have found that it may have another use. The drug has been shown to have anti-aging properties, despite no ...
CINCINNATI - The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients ...
Oxford Drug Design has announced new in vivo results that further validate its emerging first‑in‑class oncology programme, ...
Salk Institute scientists showed how an FDA-approved drug boosts the health of brain cells by limiting their energy use. Like removing unnecessary lighting from a financially strapped household to ...
Please provide your email address to receive an email when new articles are posted on . EMERYVILLE, Calif. — The European Commission has granted orphan drug status for the use of the sirolimus drug DE ...
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Santen announced that the FDA has granted orphan drug designation for sirolimus (DE-109) for the treatment of chronic/refractory anterior non-infectious uveitis, non-infectious intermediate uveitis, ...
January 12, 2010 — Healthcare professionals treating patients with sirolimus (Rapamune, Wyeth) must consider the type of laboratory assay being used for therapeutic drug monitoring, according to the ...
The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients with tuberous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback